Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury (Q43006129)

12 November 2017

title

Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury (English)

1 reference

12 November 2017

main subject

Lacticaseibacillus casei

Lacticaseibacillus paracasei

Lactobacillus paracasei

1 reference

based on heuristic

inferred from title

Lactobacillus paracasei

1 reference

Antonio Colantuoni

10

0 references

Gerardo Nardone

Gerardo Nardone

1

0 references

Alba Rocco

Alba Rocco

5

0 references

Michele Barone

Michele Barone

6

0 references

Debora Compare

2

Debora Compare

1 reference

12 November 2017

Eleonora Liguori

3

1 reference

12 November 2017

Valentina Di Mauro

4

1 reference

12 November 2017

Anna Napoli

7

1 reference

12 November 2017

Dominga Lapi

8

1 reference

12 November 2017

Maria Rosaria Iovene

9

1 reference

12 November 2017

publication date

24 June 2010

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

12 November 2017

published in

1 reference

12 November 2017

volume

299

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

G669-76

1 reference

Influence of prebiotics on the human immune system (GALT).

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

The utility of marginal donors in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Pathophysiology of ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

The impact of probiotic on gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Gut Microbiota and Its Possible Relationship With Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Hepatic microcirculation in fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Hepatic ischemia induced immediate oxidative stress after reperfusion and determined the severity of the reperfusion-induced damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

DNA from probiotic bacteria modulates murine and human epithelial and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Differential mechanisms of hepatic vascular dysregulation with mild vs. moderate ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Probiotics for preventive health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Inhibition of Kupffer cells reduced CXC chemokine production and liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

New evidence for the role of TNF-alpha in liver ischaemic/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

FAO Technical meeting on prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Cytokines and Extrahepatic Sequelae of Ischemia-Reperfusion Injury to the Liver a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Protective strategies against ischemic injury of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Inflammatory pathways in liver homeostasis and liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Using probiotics and prebiotics to improve gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

Interleukin-6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in interleukin-6-induced barrier function alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00188.2010

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00188.2010

1 reference

12 November 2017

1 reference